You mention pivoting to take advantage of lower regulations. Great call. Did you read in PAA’s quarterly they’re already speaking to clinicians in those countries while they wait for the MPL to be manufactured?
”....been engaging with clinicians in the United States as well as Eastern and Caucasus countries and The Balkans about a Phase I trial in human patients to treat COVID-19.”
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-512
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $20.93K | 102.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36959 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 71032 | 2 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |